111 related articles for article (PubMed ID: 7601562)
1. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas.
Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Akama Y; Yunotani S; Hisatsugu T; Tahara E
Int J Cancer; 1995 Jul; 62(1):25-8. PubMed ID: 7601562
[TBL] [Abstract][Full Text] [Related]
2. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
Int J Cancer; 1998 Jan; 75(1):34-9. PubMed ID: 9426687
[TBL] [Abstract][Full Text] [Related]
4. Expression of G1-->S transition regulatory molecules in human urothelial cancer.
Oya M; Schmidt B; Schmitz-Dräger BJ; Schulz WA
Jpn J Cancer Res; 1998 Jul; 89(7):719-26. PubMed ID: 9738978
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
6. Effect of cyclins and Cdks on the cyclin B1 promoter activation.
Moro A; Zerfass K; Joswig S; Jansen-Duerr P
Biochem Mol Biol Int; 1997 Apr; 41(5):919-24. PubMed ID: 9137822
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
8. Amplification of cyclin genes in colorectal carcinomas.
Leach FS; Elledge SJ; Sherr CJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(9):1986-9. PubMed ID: 8481900
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of cyclin E and cdk2 mRNAs at G1/S transition in Rat-1A cells emerging from the G0 state.
Oda S; Nishida J; Nakabeppu Y; Sekiguchi M
Oncogene; 1995 Apr; 10(7):1343-51. PubMed ID: 7731685
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.
Li JQ; Miki H; Ohmori M; Wu F; Funamoto Y
Hum Pathol; 2001 Sep; 32(9):945-53. PubMed ID: 11567224
[TBL] [Abstract][Full Text] [Related]
15. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence.
Kanazawa S; Fujiwara Y; Mizuno K
Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356
[TBL] [Abstract][Full Text] [Related]
16. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
17. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
18. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
20. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
Yamamoto H; Monden T; Miyoshi H; Izawa H; Ikeda K; Tsujie M; Ohnishi T; Sekimoto M; Tomita N; Monden M
Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
